Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 65.50
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 3.00 (4.688%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 65.50
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Board Appt and Bank Funding

14 Feb 2007 07:01

Torex Retail PLC14 February 2007 Torex Retail plc (the "Company") Appointment of New Chairman and Increased Bank Funding Torex Retail plc, a leading global retail systems provider, today provides afurther update as to its board composition and financing arrangements. The Company announces that Steve Marshall has been appointed to the main Boardwith immediate effect as Non-executive Chairman. Mr Marshall has had aprestigious career in industry, including as CEO of both Railtrack PLC and ThornPLC, having also been group finance director at both companies. He is currentlynon-executive chairman of Delta PLC and a non-executive director of BalfourBeatty PLC and Southern Water Services Ltd. He was also executive chairman ofQueens Moat Houses PLC. This appointment follows those recently of Keith Taylor as Acting ChiefExecutive Officer and Iain Lynam as Chief Restructuring Officer, all of whichconsiderably strengthen the Board's operational and corporate restructuringexperience. The Company also announces that its syndicate of banks has agreed to provide therequested additional short-term working capital facility of £15.0 million. TheBoard considers that this will be sufficient to meet the Company's short-termworking capital requirements. The £15.0 million is in addition to the Company'sexisting total banking facilities of £152.5 million comprising term loans andoverdraft facilities. The Company expects to enter into further discussions with its bankers withrespect to its medium to long term financing requirements in the next fewmonths, when the Company has finalised results for the financial year ended 31December 2006 and has an up to date view of the 2007/2008 trading prospects. The Board is very pleased that it has concluded discussions with the Company'slenders with respect to its short-term financing requirements and that theCompany's lenders remain supportive. The Board is also delighted to haveappointed somebody of the calibre of Steve Marshall, whose experience andguidance will be of great benefit to the Company during this period. - Ends - Enquiries: Keith Taylor Acting CEO, Torex Retail plc Tel: 0870 300 6061 Ginny Pulbrook / Seb Hoyle / Lucie Holloway Citigate Dewe Rogerson Tel: 020 7638 9571 Additional details are set out below: Steve Marshall (age 50) Present directorships or partnerships: Delta PLC, Balfour Beatty PLC, SouthernWater Services Ltd Directorships or partnerships in previous five years: Queens Moat Houses PLC,Railtrack Group PLC Details of companies entering insolvency whilst a director or within 12 monthsof resignation: RT Group Holdings Ltd No unspent convictions, bankruptcy or IVAs, no receivership of assets, no publiccriticism by regulatory bodies. There is nothing further to disclose in relation to their appointment pursuantto Rule 17 of the AIM Rules. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
17th Oct 20143:35 pmRNSInitial Clinical Trial Results
10th Sep 20149:00 amRNSdCELL® technology presented at Royal Society event
30th Jul 20147:00 amRNSUK meniscus clinical trial & DermaPure US updates
25th Jul 20147:00 amRNSTissue Regenix adds European bladder matrix patent
18th Jul 201411:11 amRNSIssue of equity and total voting rights
27th Jun 20143:06 pmRNSResult of AGM
12th Jun 20147:00 amRNSTissue Regenix announces launch of DermaPure in US
22nd May 20147:00 amRNSPreliminary Decision to Approve "Q" Code Request
20th May 20147:00 amRNSDeferred Annual Bonus Award
19th May 201410:21 amRNSAnnual Report & Accounts and Notice of AGM
19th May 20147:00 amRNSPreliminary results for year ended 31 January 2014
16th May 20141:00 pmRNSTissue Regenix adds US patent
12th May 201411:00 amRNSNotice of Preliminary Results
30th Apr 20145:14 pmRNSHolding(s) in Company
28th Apr 20147:00 amRNSTissue Regenix adds Chinese patent
24th Apr 20148:40 amRNSHolding(s) in Company
4th Feb 20143:03 pmRNSIssue of Share Options
31st Jan 20141:11 pmRNSHolding(s) in Company
14th Jan 20145:22 pmRNSIssue of equity and total voting rights
9th Jan 201411:11 amRNSIssue of equity and total voting rights
19th Dec 20137:00 amRNSTissue Regenix to attend JPMorgan Healthcare Event
12th Dec 20137:00 amRNSTissue Regenix signs US distribution agreements
22nd Nov 20137:00 amRNSDirector Share Purchase
29th Oct 20137:00 amRNSPresentation at Proactiveinvestors Forum in Dublin
28th Oct 20134:49 pmRNSDirector Share Purchase
21st Oct 20137:00 amRNSPublication of DermaPure UK trial results
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
17th Oct 20134:41 pmRNSHolding(s) in Company
14th Oct 20137:00 amRNSTissue Regenix USA successful technology transfer
8th Oct 20137:00 amRNSInterim Results for six months ended 31 July 2013
12th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Marketing
6th Aug 20139:41 amRNSHolding(s) in Company
5th Aug 20137:00 amRNSTissue Regenix USA Appoints VP of Operations
29th Jul 20138:45 amRNSTissue Regenix Key Appointment at USA Subsidiary
25th Jul 20134:59 pmRNSHolding(s) in Company
17th Jul 20137:00 amRNSAppointment of Non-Executive Director
10th Jul 20137:00 amRNSAppointment of Non-Executive Director
18th Jun 20137:00 amRNSTissue Regenix advances US commercialisation
14th Jun 201312:43 pmRNSResult of AGM
14th Jun 20137:00 amRNSPresentation of dCELL at heart valve event
28th May 20137:00 amRNSAppointment of Business Development Manager
14th May 20133:47 pmRNSAnnual Report and Notice of AGM
13th May 20137:00 amRNSPreliminary results for the year ended 31 Jan 2013
3rd May 20137:00 amRNSNotice of Results
2nd May 20137:00 amRNSResults of dCELL Dermis trial
29th Apr 20137:00 amRNSChange of Nominated Adviser and Broker
16th Apr 20137:00 amRNSApproval for start of clinical research trial
2nd Apr 20137:00 amRNSTissue Regenix makes appointment to US subsidiary
11th Mar 20137:00 amRNSDirector Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.